Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-17-010284
Filing Date
2017-02-22
Accepted
2017-02-22 06:05:49
Documents
9
Period of Report
2017-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v460062_6k.htm 6-K 22746
2 EXHIBIT 5.1 v460062_ex5-1.htm EX-5.1 7206
3 EXHIBIT 10.1 v460062_ex10-1.htm EX-10.1 48808
4 EXHIBIT 10.2 v460062_ex10-2.htm EX-10.2 9702
5 EXHIBIT 10.3 v460062_ex10-3.htm EX-10.3 215071
6 EXHIBIT 10.4 v460062_ex10-4.htm EX-10.4 104538
7 GRAPHIC pg1img1_ex10-2.jpg GRAPHIC 18668
8 GRAPHIC pg1img1_ex10-1.jpg GRAPHIC 18492
9 GRAPHIC logo.jpg GRAPHIC 16480
  Complete submission text file 0001144204-17-010284.txt   483326
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 17626987
SIC: 2834 Pharmaceutical Preparations